Promising Outcome From Collaboration With Dundee Sustainable Technologies GlobeNewswire August 18, 2025 TORONTO, Aug. 18, 2025 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is pleased to announce promising results from a program of metallurgical testing undertaken in collaboration with Dundee Sustainable Technologies (“DST”), a subsidiary of Dundee […]
Global Loitering Munition Market Set for Steady Growth to $815.3 Million by 2029 GlobeNewswire August 18, 2025 Delray Beach, FL, Aug. 18, 2025 (GLOBE NEWSWIRE) — The report “Loitering Munition Market by Type (Recoverable and Expendable), Launch Mode (Air Launched Effect, Vertical Take-Off, Catapult Launched, Canister Launched, Hand Launched), End User, Range and Region –
OneMedNet initiates new Subscription Revenue model in partnership with Circle CVI GlobeNewswire August 18, 2025 MINNEAPOLIS, Aug. 18, 2025 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD) announced a long-term strategic partnership with Circle Cardiovascular Imaging Inc. (Circle CVI), a global leader in advanced cardiovascular imaging
Plus Therapeutics Presents Positive ReSPECT-LM Clinical Trial Results of REYOBIQ(TM) in Leptomeningeal Metastases GlobeNewswire August 18, 2025 REYOBIQ produced a clinical benefit rate of over 75% in 3 clinically relevant outcome measures RNA sequencing and circulating tumor cell reduction consistent with tumor cell death No dose limiting toxicities were observed with an overall favorable safety
Reunion Neuroscience Announces Positive Topline Results from RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD) GlobeNewswire August 18, 2025 — Achieved Primary Endpoint with 30mg Dose of RE104 Demonstrating 23.0-Point Reduction from Baseline in Montgomery-Asberg Depression Rating Scale (MADRS) Score on Day 7, a 5.8-Point Greater Reduction Than Patients
NEW YORK, NY / ACCESS Newswire / August 18, 2025 / If you suffered a loss on your Sable Offshore Corp. (NYSE:SOC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sable-offshore-corp-lawsuit-submission-form?prid=161976&wire=1&utm_campaign=27 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 18, 2025 / If you suffered a loss on your Replimune Group, Inc. (NASDAQ:REPL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=161977&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Snap Inc. ("Snap Inc.") (NYSE:SNAP) concerning possible violations of federal securities laws. Investors.com reported on August 6, 2025, that "Snap . . . stock tumbled Wednesday after the Snapchat parent company posted
NEW YORK, NY / ACCESS Newswire / August 18, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form-3?prid=161987&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 18, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Thomson Reuters Corporation ("Thomson Reuters Corporation") (NASDAQ:TRI) concerning possible violations of federal securities laws. On August 6, 2025, Thomson Reuters published a press release reporting the Company’s second quarter 2025 results. During